Eicosapentaenoic acid/docosahexaenoic acid 1:1 ratio improves histological alterations in obese rats with metabolic syndrome

Lipids in Health and Disease

Volumn 13, Issue 1, 2014, Pages

  Taltavull, Núria ^a   Muñoz Cortés, Mònica ^a   Lluís, Laura ^a   Jové, Montserrat ^a   Fortuño, Àngels ^b   Molinar Toribio, Eunice ^c   Torres, Josep Lluís ^c   Pazos, Manuel ^d   Medina, Isabel ^d   Nogués, M Rosa ^a  

^a UNIVERSITAT ROVIRA I VIRGILI   (Spain)

^b Eldine Pathology Laboratory   (Spain)

^c INSTITUTE OF ADVANCED CHEMISTRY OF CATALONIA IQAC CSIC   (Spain)

^d INSTITUTO DE INVESTIGACIONES MARINAS   (Spain)

Author keywords

EPA DHA ratio; Fish oils; Histology; Metabolic syndrome; Omega 3 polyunsaturated fatty acids; SHROB rats

Indexed keywords

ABDOMINAL FAT; ANIMALS; AORTA; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; DRUG EVALUATION, PRECLINICAL; EICOSAPENTAENOIC ACID; KIDNEY; LIVER; METABOLIC SYNDROME X; OBESITY; RATS; RATS, WISTAR;

EID: 84893665562     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-13-31     Document Type: Article

References (30)

1. Dietary sources of omega 3 fatty acids: public health risks and benefits. Tur JA, Bibiloni MM, Sureda A, Pons A, Br J Nutr 2012 107 23 52 10.1017/S0007114512001456
2. Mataix Verdú J, Nutrición y Alimentación Humana Spain: Ergon 2009 1238 1239
3. The effect of EPA and DHA on metabolic syndrome patients: a systematic review of randomised controlled trials. López-Huertas E, Br J Nutr 2012 107 185 194 10.1017/S0007114512001572
4. Protective effect of the omega-3 polyunsaturated fatty acids:eicosapentaenoic acid/docosahexaenoic acid 1:1 ratio on cardiovascular disease risk markers in rats. Lluís L, Taltavull N, Muñoz- Cortés M, Sanchez-Martos V, Romeu M, Giralt M, et al. Lipids Health Dis 2013 12 140 10.1186/1476-511X-12-140 24083393
5. Effect of omega-3 fatty acids and other food supplements on elderly-related pathological processes. Rueda F, Domingo JC, Mach N, Rev Esp Nutr Hum Diet 2011 15 1 20 29
6. Dietary polyunsaturated fatty acids improve histological and biochemical alterations in rats with experimental ulcerative colitis. Nieto N, Torres MI, Ríos A, Gil A, J Nutr 2002 132 11 19 11773501 (Pubitemid 34042448)
7. Rethinking lipid mediators. Weylandt KH, Kang JX, Lancet 2005 366 618 620 10.1016/S0140-6736(05)67119-X 16112288 (Pubitemid 41176007)
8. Recommended dietary reference intakes, nutritional goals and dietary guidelines for fat and fatty acids: a systematic review. Aranceta J, Pérez-Rodrigo C, Br J Nutr 2012 107 8 22 10.1017/S0007114512001444
9. N-3 Fatty acids and cardiovascular disease: actions and molecular mechanisms. Torrejon C, Jung UJ, Deckelbaum RJ, Prostaglandins Leukot Essent Fatty Acids 2007 77 5-6 319 326 18060753 (Pubitemid 350198858)
10. Effect of B-vitamins and n-3 PUFA supplementation for 5 years on blood pressure in patients with CVD. Vergnaud AC, Ahluwalia N, Julia C, Hercberg S, Blacher J, Galan P, Szabo De Edelenyi F, Br J Nutr 2012 107 921 927 10.1017/S0007114511003692 21801476
11. Different biomechanical properties of medial and adventitial layers of thoracic aorta in Wistar-Kyoto and spontaneously hypertensive rats. Han WQ, Chen J, Wu LY, Zhu DL, Gao PJ, Acta Pharmacol Sin 2010 31 1319 1323 10.1038/aps.2010.121 20802506
12. Effectes of dietary fish oil trans fat on rat aorta histopayhology and cardiovascular risk markers. Park S, Park Y, Nutr Res Pract 2009 3 2 102 107 10.4162/nrp.2009.3.2.102 20016709
13. Effects of docosahexaenoic acid on vascular pathology and reactivity in hypertension. Engler MM, Engler MB, Pierson DM, Molteni LB, Molteni A, Exp Biol Med (Maywood) 2003 228 299 307 12626775 (Pubitemid 36314497)
14. Passive mechanical properties and structure of aorta: segmental analysis. Sokolis DP, Acta Physiol 2007 190 277 289 10.1111/j.1748-1716.2006.01661.x (Pubitemid 47063377)
15. The inhibition of fat cell proliferation by n-3 fatty acids in dietary obese mice. Hensler M, Bardova K, Jilkova ZM, Wahli W, Meztger D, Chambon P, Kopecky J, Flachs P, Lipids Health Dis 2011 10 128 10.1186/1476-511X-10-128 21810216
16. The function of porcine PPARγ and dietary fish oil effect on the expression of lipid and glucose metabolism related genes. Yu-Hsiang Y, et al. J Nutr Biochem 2011 22 179 186 10.1016/j.jnutbio.2010.01.006 20970313
17. Omega-3 fatty acids and metabolic syndrome: effects and emerging mechanisms of action. Poudyal H, Panchal SK, Diwan V, Brown L, Prog Lipid Res 2011 50 372 387 10.1016/j.plipres.2011.06.003 21762726
18. Mechanisms of action of (n-3) fatty acids. Calder PC, J Nutr 2012 142 592S 599S 10.3945/jn.111.155259 22279140
19. Hepatic and biochemical repercussions of a polyunsaturated fat-rich hypercaloric and hyperlipidic diet in wistar rats. Burlamaqui IM, Dornelas CA, Valenca JT Jr, Mesquita FJ, Veras LB, Rodrigues LV, Arq Gastroenterol 2011 48 2 153 158 10.1590/S0004-28032011000200012 21709958
20. Hepatic steatosis in n-3 fatty acid depleted mice: focus on metabolic alterations related to tissue fatty acid composition. Pachikian BD, Neyrinck AM, Cani PD, Portois L, Deldicque L, De Backer FC, et al. BMC Physiol 2008 8 21 10.1186/1472-6793-8-21 19046413
21. Long-term effect of eicosapentaenoic acid ethyl (EPA-E) on albuminuria of non-insulin dependent diabetic patients. Shimizu H, Ohtani K, Tanaka Y, Sato N, Mori M, Shimomura Y, Diab Res Clin Pract 1995 28 35 40 10.1016/0168-8227(95) 01056-J
22. Polyunsaturated fatty acids and renal fibrosis: pathophysiologic link and potential clinical implications. Baggio B, Musacchio E, Priante G, J Nephrol 2005 18 362 367 16245238 (Pubitemid 41700097)
23. High linoleic acid diets ameliorate diabetic nephropathy in rats. Barcelli UO, Weiss M, Beach D, Motz A, Thompson B, Am J Kidney Dis 1990 16 244 251 2399916 (Pubitemid 20342443)
24. Omega-3 fatty acid rich diet prevents diabetic renal disease. Garman JH, Mulroney S, Manigrasso M, Flynn E, Maric C, Am J Physiol Renal Physiol 2009 296 306 16 19052104
25. Experimental rat models to study the metabolic syndrome. Aleixandre De Artiñano A, Miguel M, Br J Nutr 2009 102 1246 1253 10.1017/ S0007114509990729 19631025
26. Scientific opinion of the panel on dietetic products, nutrition and allergies on a request from European commission related to labelling reference intake values for n-3 and n-6 polyunsaturated fatty acids. EFSA, EFSA J 2009 1176 1 11
27. Reduced protein oxidation in wistar rats supplemented with marine OMEGA-3 PUFA. Méndez L, Pazos M, Gallardo JM, Torres JL, Pérez- Jiménez J, Nogués MR, Romeu M, Medina I, Free Radic Biol Med 2012 11 004 doi: 10.1016/j.freeradbiomed
28. Long-term treatment with angiotensin II receptor blocker decreases adipocyte size and improves insulin signalling in obese zucker rats. Muñoz MC, Giani JF, Dominici FP, Turyn D, Toblli JE, Ann N Y Acad Sci 2009 27 2409 2420
29. Characterization of high-fat, diet-induced, non-alcoholic steatohepatitis with fibrosi in rats. Xu ZJ, Fan JG, Ding XD, Qiao L, Wang GL, Dig Dis Sci 2010 55 931 40 10.1007/s10620-009-0815-3 19459046
30. Effect of salt on hypertension and oxidative stress in rat model of diet-induced obesity. Dobrian AD, Schirver SD, Lynch T, Prewitt RL, Am J Physiol Renal Physiol 2003 285 619 28 12799306